Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-oxiracetam in craniocerebral injury
NCT04205565Phase 3Recruiting
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Start
- Sep 2019
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levoxiracetam in Craniocerebral trauma, sponsored by Nanjing Yoko Biomedical Co., Ltd.. Started Sep 2019; status: recruiting.
02
Drugs
levoxiracetam
03
Conditions
Craniocerebral trauma
Beyond the preview
Go deeper on NCT04205565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205565.